Pharmacological therapies to prevent the development and progression of calcific aortic valve stenosis are currently under wide investigation, with potential breakthroughs anticipated.
Do pharmacotherapeutic agents prevent the development and progression of calcific aortic valve stenosis?
This review highlights ongoing investigations into pharmacological therapies aimed at preventing or slowing the progression of calcific aortic valve stenosis.
Absolute Event Rate: 0% vs 0%
AS is an active, pathological disease which should be amenable to pharmacological modulation. A wide spectrum of pharmacotherapeutic agents are currently being investigated and the authors of this review are optimistic that we might be on the cusp of a breakthrough.
Courtney et al. (Tue,) reported a other. Pharmacological therapies to prevent the development and progression of calcific aortic valve stenosis are currently under wide investigation, with potential breakthroughs anticipated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: